I don't think there is any need to worry about quality. Because the procurement of the heart stent is organized by the state, it is a state-led purchase of medicines and medical equipment that are in great demand in the community. In short, it means that the state is communicating directly with the pharmaceutical companies instead of the people, eliminating the need for a secondary interface with the seller, which means that the price is lower. At the same time, because the state to buy belongs to the commodity economy in the thin profit, which means that the price, in fact, has been close to the cost price.
Although from another angle, we can also see the profiteering of the pharmaceutical industry, but now we can use the lowest price to buy the best quality, why not? In terms of quality, it has also gone through a national level quality check to confirm that there will be no fluctuation in quality again and again. In the third national list of medicines purchased in quantities, we can see a lot of names that we can usually see, including some common medicines for common diseases and some hardware that is just needed for special surgeries, such as cardiac stents mentioned in the title, are among the ranks.
How much can nationwide banded purchasing actually save for all the people? According to national statistics, these three batches of drug banding purchase cage*** can save more than 50 billion dollars. Although different from the drug bandwidth purchase as simple, like the heart stent such high-value medical consumables equipment bandwidth purchase some difficulties, because different from the drug has a unified efficacy standards, the heart stent, such equipment is also closely related to the surgical process, in the clinical use, it is more varied.
But because of the high demand for cardiac stents and the competition in the market, the state has taken advantage of the condition of being able to compete adequately and made cardiac stents as high-value medical consumable devices the top choice for bandwagon purchasing. This also reduces the pressure on both hospitals and patients in many places. The cost of surgery for hospitals will be reduced, the pressure on the health insurance fund will be reduced, and the economic burden on patients will be greatly reduced. So although the national volume purchasing of cardiac stents is cheap, but still can believe in the quality, you can rest assured that the use.